AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,003,000 | +46.6% | 436,183 | +202.7% | 0.01% | +40.0% |
| Q4 2021 | $684,000 | +65.6% | 144,093 | +143.0% | 0.01% | +66.7% |
| Q2 2021 | $413,000 | -72.5% | 59,294 | -68.7% | 0.00% | -75.0% |
| Q1 2021 | $1,500,000 | +63.9% | 189,433 | +62.9% | 0.01% | +50.0% |
| Q4 2020 | $915,000 | -46.6% | 116,267 | -51.9% | 0.01% | -55.6% |
| Q3 2020 | $1,712,000 | +820.4% | 241,476 | +505.2% | 0.02% | +800.0% |
| Q1 2020 | $186,000 | -43.3% | 39,903 | -16.6% | 0.00% | -60.0% |
| Q2 2019 | $328,000 | +131.0% | 47,853 | +257.7% | 0.01% | +150.0% |
| Q2 2018 | $142,000 | +67.1% | 13,379 | -14.7% | 0.00% | +100.0% |
| Q4 2017 | $85,000 | – | 15,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 524,929 | $2,588,000 | 6.20% |
| DAFNA Capital Management LLC | 349,592 | $1,723,000 | 1.07% |
| Nantahala Capital Management | 1,602,903 | $7,902,000 | 0.39% |
| Sio Capital Management, LLC | 129,583 | $639,000 | 0.33% |
| Rock Springs Capital Management LP | 524,089 | $2,584,000 | 0.12% |
| Orbimed Advisors | 1,469,524 | $7,244,000 | 0.07% |
| Baker Brothers Advisors | 1,137,872 | $5,609,000 | 0.04% |
| Lee Financial Co | 22,408 | $110,000 | 0.04% |
| Spark Investment Management LLC | 42,002 | $207,000 | 0.01% |
| JENNISON ASSOCIATES LLC | 1,385,067 | $6,565,000 | 0.01% |